

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | purine nucleobase biosynthetic process (GO:0009113) | 4.31008142 |
| 2 | DNA replication checkpoint (GO:0000076) | 4.27359325 |
| 3 | mitotic metaphase plate congression (GO:0007080) | 4.20771097 |
| 4 | nucleobase biosynthetic process (GO:0046112) | 4.16746722 |
| 5 | DNA replication initiation (GO:0006270) | 4.13597669 |
| 6 | maturation of SSU-rRNA (GO:0030490) | 4.09392878 |
| 7 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.07263169 |
| 8 | negative regulation of ligase activity (GO:0051352) | 4.07263169 |
| 9 | DNA deamination (GO:0045006) | 3.95476054 |
| 10 | ribosome biogenesis (GO:0042254) | 3.92934280 |
| 11 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.89721358 |
| 12 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.87384099 |
| 13 | CENP-A containing nucleosome assembly (GO:0034080) | 3.80966573 |
| 14 | ribosomal small subunit assembly (GO:0000028) | 3.77702697 |
| 15 | establishment of integrated proviral latency (GO:0075713) | 3.77442790 |
| 16 | DNA strand elongation (GO:0022616) | 3.76909954 |
| 17 | chromatin remodeling at centromere (GO:0031055) | 3.68210002 |
| 18 | rRNA modification (GO:0000154) | 3.63763604 |
| 19 | telomere maintenance via recombination (GO:0000722) | 3.60332217 |
| 20 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.60315520 |
| 21 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.58261289 |
| 22 | proteasome assembly (GO:0043248) | 3.57756315 |
| 23 | metaphase plate congression (GO:0051310) | 3.56030725 |
| 24 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.54622100 |
| 25 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.54511216 |
| 26 | positive regulation of ligase activity (GO:0051351) | 3.50218014 |
| 27 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.49621745 |
| 28 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.49621745 |
| 29 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.49541284 |
| 30 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.49541284 |
| 31 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.49541284 |
| 32 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.48571166 |
| 33 | termination of RNA polymerase III transcription (GO:0006386) | 3.48571166 |
| 34 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.46229806 |
| 35 | DNA replication-independent nucleosome organization (GO:0034724) | 3.44140786 |
| 36 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.44140786 |
| 37 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.43840740 |
| 38 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.43840740 |
| 39 | chaperone-mediated protein transport (GO:0072321) | 3.43835574 |
| 40 | formation of translation preinitiation complex (GO:0001731) | 3.40190172 |
| 41 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.37305648 |
| 42 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.36845389 |
| 43 | kinetochore organization (GO:0051383) | 3.35121622 |
| 44 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.33546088 |
| 45 | mitotic recombination (GO:0006312) | 3.32093412 |
| 46 | rRNA processing (GO:0006364) | 3.31541372 |
| 47 | kinetochore assembly (GO:0051382) | 3.30930740 |
| 48 | maturation of 5.8S rRNA (GO:0000460) | 3.30135066 |
| 49 | 7-methylguanosine mRNA capping (GO:0006370) | 3.28797097 |
| 50 | establishment of viral latency (GO:0019043) | 3.28410333 |
| 51 | RNA capping (GO:0036260) | 3.28323105 |
| 52 | 7-methylguanosine RNA capping (GO:0009452) | 3.28323105 |
| 53 | regulation of ligase activity (GO:0051340) | 3.27860461 |
| 54 | mitotic chromosome condensation (GO:0007076) | 3.26809058 |
| 55 | protein localization to kinetochore (GO:0034501) | 3.25498351 |
| 56 | ribosomal large subunit biogenesis (GO:0042273) | 3.25012094 |
| 57 | establishment of chromosome localization (GO:0051303) | 3.24615613 |
| 58 | telomere maintenance via telomere lengthening (GO:0010833) | 3.22337692 |
| 59 | rRNA metabolic process (GO:0016072) | 3.22130024 |
| 60 | histone exchange (GO:0043486) | 3.20717497 |
| 61 | spliceosomal snRNP assembly (GO:0000387) | 3.20151093 |
| 62 | ribosome assembly (GO:0042255) | 3.19998581 |
| 63 | rRNA methylation (GO:0031167) | 3.18446417 |
| 64 | regulation of spindle organization (GO:0090224) | 3.16533622 |
| 65 | ribosomal small subunit biogenesis (GO:0042274) | 3.16372262 |
| 66 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.16182528 |
| 67 | mitotic nuclear envelope disassembly (GO:0007077) | 3.15667431 |
| 68 | negative regulation of protein ubiquitination (GO:0031397) | 3.15172376 |
| 69 | mitochondrial RNA metabolic process (GO:0000959) | 3.14600082 |
| 70 | protein targeting to mitochondrion (GO:0006626) | 3.11319477 |
| 71 | termination of RNA polymerase I transcription (GO:0006363) | 3.10898764 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.10661697 |
| 73 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.07089097 |
| 74 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.06206826 |
| 75 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.05651771 |
| 76 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.04267815 |
| 77 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.04267815 |
| 78 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.03335396 |
| 79 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.03065978 |
| 80 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.02218409 |
| 81 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.00665006 |
| 82 | protein localization to chromosome, centromeric region (GO:0071459) | 2.98825489 |
| 83 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.98024292 |
| 84 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.97809826 |
| 85 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.97452232 |
| 86 | transcription from RNA polymerase I promoter (GO:0006360) | 2.97387419 |
| 87 | protein localization to mitochondrion (GO:0070585) | 2.96869747 |
| 88 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.95530757 |
| 89 | mitotic spindle assembly checkpoint (GO:0007094) | 2.94949058 |
| 90 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.94577062 |
| 91 | IMP biosynthetic process (GO:0006188) | 2.94386983 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.94011790 |
| 93 | regulation of mitochondrial translation (GO:0070129) | 2.93960915 |
| 94 | sister chromatid segregation (GO:0000819) | 2.92585209 |
| 95 | meiotic chromosome segregation (GO:0045132) | 2.90236928 |
| 96 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.89734537 |
| 97 | nuclear pore organization (GO:0006999) | 2.88935798 |
| 98 | spindle assembly checkpoint (GO:0071173) | 2.88045779 |
| 99 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.87774083 |
| 100 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.86276147 |
| 101 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.85127962 |
| 102 | membrane disassembly (GO:0030397) | 2.84588226 |
| 103 | nuclear envelope disassembly (GO:0051081) | 2.84588226 |
| 104 | DNA-dependent DNA replication (GO:0006261) | 2.84342205 |
| 105 | pseudouridine synthesis (GO:0001522) | 2.82649173 |
| 106 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.81935271 |
| 107 | spindle checkpoint (GO:0031577) | 2.81749270 |
| 108 | protein K6-linked ubiquitination (GO:0085020) | 2.81191868 |
| 109 | cullin deneddylation (GO:0010388) | 2.80718304 |
| 110 | viral mRNA export from host cell nucleus (GO:0046784) | 2.80698546 |
| 111 | cell cycle G1/S phase transition (GO:0044843) | 2.79219556 |
| 112 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.79219556 |
| 113 | establishment of protein localization to mitochondrion (GO:0072655) | 2.78930331 |
| 114 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.77434115 |
| 115 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.74725210 |
| 116 | nuclear pore complex assembly (GO:0051292) | 2.74165006 |
| 117 | positive regulation of chromosome segregation (GO:0051984) | 2.74059224 |
| 118 | telomere maintenance (GO:0000723) | 2.73553724 |
| 119 | telomere organization (GO:0032200) | 2.73209781 |
| 120 | IMP metabolic process (GO:0046040) | 2.72887208 |
| 121 | cellular component biogenesis (GO:0044085) | 2.72513621 |
| 122 | folic acid metabolic process (GO:0046655) | 2.72337337 |
| 123 | histone mRNA metabolic process (GO:0008334) | 2.70426040 |
| 124 | mitotic sister chromatid segregation (GO:0000070) | 2.70077269 |
| 125 | * DNA-templated transcription, termination (GO:0006353) | 2.69820325 |
| 126 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.68429064 |
| 127 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.68030950 |
| 128 | DNA synthesis involved in DNA repair (GO:0000731) | 2.67895821 |
| 129 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.67505024 |
| 130 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.67505024 |
| 131 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.67505024 |
| 132 | negative regulation of sister chromatid segregation (GO:0033046) | 2.67505024 |
| 133 | negative regulation of chromosome segregation (GO:0051985) | 2.66047998 |
| 134 | translational termination (GO:0006415) | 2.65778122 |
| 135 | viral transcription (GO:0019083) | 2.65173720 |
| 136 | DNA-templated transcription, elongation (GO:0006354) | 2.64734557 |
| 137 | mitotic spindle checkpoint (GO:0071174) | 2.64129115 |
| 138 | regulation of chromosome segregation (GO:0051983) | 2.62701303 |
| 139 | DNA unwinding involved in DNA replication (GO:0006268) | 2.62554015 |
| 140 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.61741362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.62755774 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.80228051 |
| 3 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.45818361 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.42520726 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.40987859 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.21130962 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.16661907 |
| 8 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.05873909 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.05003941 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.97701144 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.79472438 |
| 12 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.78226060 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.75980354 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.65736229 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.61644611 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.52544392 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.52375276 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46041296 |
| 19 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.34490872 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.31196504 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.30518981 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.28441951 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.24611520 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.12624021 |
| 25 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.09400450 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.05006832 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.03137494 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.00004802 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93099963 |
| 30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.92358328 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.89588234 |
| 32 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.86459405 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.82125732 |
| 34 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.77939364 |
| 35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.77755197 |
| 36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76669684 |
| 37 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.76420922 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.76230882 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.72985908 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.71977567 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.71718964 |
| 42 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.70077689 |
| 43 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67943733 |
| 44 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.66842534 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.65717518 |
| 46 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.64651311 |
| 47 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59942539 |
| 48 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58288289 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58025628 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57584478 |
| 51 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55135449 |
| 52 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.51427977 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.51278080 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45546536 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44659355 |
| 56 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41345694 |
| 57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40303756 |
| 58 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.36772329 |
| 59 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33786195 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33671530 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30384109 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29351744 |
| 63 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.26907245 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.26159273 |
| 65 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.24261871 |
| 66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.23954950 |
| 67 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.21119671 |
| 68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17159509 |
| 69 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.14511698 |
| 70 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12595481 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12514080 |
| 72 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12423796 |
| 73 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10727306 |
| 74 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02736340 |
| 75 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.02075698 |
| 76 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.00932178 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00399928 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 1.00149286 |
| 79 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98105884 |
| 80 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.97198437 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96954375 |
| 82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95437799 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95165713 |
| 84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95071405 |
| 85 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94407416 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91909112 |
| 87 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.88842936 |
| 88 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88085300 |
| 89 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.86718383 |
| 90 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86542868 |
| 91 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.84239463 |
| 92 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.83667521 |
| 93 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.83601704 |
| 94 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.82614500 |
| 95 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.82326059 |
| 96 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80419587 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78218083 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.77846223 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 0.77666159 |
| 100 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.76931406 |
| 101 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.75944258 |
| 102 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.74879827 |
| 103 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.74318031 |
| 104 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.74285382 |
| 105 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.73890795 |
| 106 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.73724896 |
| 107 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73163996 |
| 108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73111720 |
| 109 | MYB_26560356_Chip-Seq_TH2_Human | 0.72954252 |
| 110 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.72802612 |
| 111 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.72631338 |
| 112 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.72504567 |
| 113 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.72375052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.10902526 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.26267270 |
| 3 | MP0008057_abnormal_DNA_replication | 4.25470642 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.83907078 |
| 5 | MP0008058_abnormal_DNA_repair | 3.63043571 |
| 6 | MP0003077_abnormal_cell_cycle | 3.49924683 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 3.43356816 |
| 8 | MP0008007_abnormal_cellular_replicative | 2.84245719 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.44288472 |
| 10 | MP0002254_reproductive_system_inflammat | 2.20207175 |
| 11 | MP0003718_maternal_effect | 2.19273875 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.15617849 |
| 13 | MP0003786_premature_aging | 2.12413529 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.09034603 |
| 15 | MP0003763_abnormal_thymus_physiology | 1.92588892 |
| 16 | MP0005671_abnormal_response_to | 1.90065487 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 1.84596861 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.84396230 |
| 19 | MP0008877_abnormal_DNA_methylation | 1.78736874 |
| 20 | MP0006035_abnormal_mitochondrial_morpho | 1.77495085 |
| 21 | MP0000350_abnormal_cell_proliferation | 1.72385092 |
| 22 | MP0000490_abnormal_crypts_of | 1.71530439 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.68171630 |
| 24 | MP0009785_altered_susceptibility_to | 1.66793658 |
| 25 | MP0001730_embryonic_growth_arrest | 1.63169639 |
| 26 | MP0002132_abnormal_respiratory_system | 1.59948555 |
| 27 | MP0002398_abnormal_bone_marrow | 1.58963470 |
| 28 | MP0008789_abnormal_olfactory_epithelium | 1.52937595 |
| 29 | MP0003186_abnormal_redox_activity | 1.49449266 |
| 30 | MP0001800_abnormal_humoral_immune | 1.48808659 |
| 31 | MP0003941_abnormal_skin_development | 1.45648296 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.44149877 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.41426203 |
| 34 | MP0010307_abnormal_tumor_latency | 1.38734392 |
| 35 | MP0002722_abnormal_immune_system | 1.37652455 |
| 36 | MP0002210_abnormal_sex_determination | 1.35421503 |
| 37 | MP0002019_abnormal_tumor_incidence | 1.33979423 |
| 38 | MP0000313_abnormal_cell_death | 1.32961324 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.32808929 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.32808929 |
| 41 | MP0000685_abnormal_immune_system | 1.32072348 |
| 42 | MP0002723_abnormal_immune_serum | 1.31125487 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.29827926 |
| 44 | MP0000716_abnormal_immune_system | 1.28188563 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.27610968 |
| 46 | MP0002429_abnormal_blood_cell | 1.26654805 |
| 47 | MP0001819_abnormal_immune_cell | 1.26040480 |
| 48 | MP0003123_paternal_imprinting | 1.24994557 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.23943639 |
| 50 | MP0005025_abnormal_response_to | 1.21746816 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.19315864 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.18620800 |
| 53 | MP0001929_abnormal_gametogenesis | 1.18549356 |
| 54 | MP0001853_heart_inflammation | 1.18255256 |
| 55 | MP0005380_embryogenesis_phenotype | 1.17338522 |
| 56 | MP0001672_abnormal_embryogenesis/_devel | 1.17338522 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.16882900 |
| 58 | MP0005501_abnormal_skin_physiology | 1.14880546 |
| 59 | MP0002006_tumorigenesis | 1.12537199 |
| 60 | MP0002405_respiratory_system_inflammati | 1.12339506 |
| 61 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12048494 |
| 62 | MP0003724_increased_susceptibility_to | 1.11508108 |
| 63 | MP0001764_abnormal_homeostasis | 1.11458660 |
| 64 | MP0001145_abnormal_male_reproductive | 1.11100343 |
| 65 | MP0001697_abnormal_embryo_size | 1.09390050 |
| 66 | MP0000516_abnormal_urinary_system | 1.08352807 |
| 67 | MP0005367_renal/urinary_system_phenotyp | 1.08352807 |
| 68 | MP0005410_abnormal_fertilization | 1.08271745 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.05617331 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.05247840 |
| 71 | MP0002080_prenatal_lethality | 1.03582546 |
| 72 | MP0003984_embryonic_growth_retardation | 1.03364811 |
| 73 | MP0002009_preneoplasia | 1.02846088 |
| 74 | MP0004147_increased_porphyrin_level | 1.02320698 |
| 75 | MP0002160_abnormal_reproductive_system | 1.02151460 |
| 76 | MP0005499_abnormal_olfactory_system | 1.00485146 |
| 77 | MP0005394_taste/olfaction_phenotype | 1.00485146 |
| 78 | MP0002166_altered_tumor_susceptibility | 1.00368176 |
| 79 | MP0000653_abnormal_sex_gland | 0.99567920 |
| 80 | MP0002088_abnormal_embryonic_growth/wei | 0.99295998 |
| 81 | MP0009764_decreased_sensitivity_to | 0.98844811 |
| 82 | MP0002419_abnormal_innate_immunity | 0.98642448 |
| 83 | MP0003436_decreased_susceptibility_to | 0.97194677 |
| 84 | MP0001790_abnormal_immune_system | 0.96799790 |
| 85 | MP0005387_immune_system_phenotype | 0.96799790 |
| 86 | MP0001119_abnormal_female_reproductive | 0.96719904 |
| 87 | MP0005389_reproductive_system_phenotype | 0.96536759 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.95991065 |
| 89 | MP0000858_altered_metastatic_potential | 0.94043136 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.94003979 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.93475098 |
| 92 | MP0008260_abnormal_autophagy | 0.93429686 |
| 93 | MP0009697_abnormal_copulation | 0.93084889 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.92889857 |
| 95 | MP0002796_impaired_skin_barrier | 0.85861528 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.85011288 |
| 97 | MP0002085_abnormal_embryonic_tissue | 0.83384926 |
| 98 | MP0002086_abnormal_extraembryonic_tissu | 0.82999643 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.80497981 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.78874576 |
| 101 | MP0008873_increased_physiological_sensi | 0.78524888 |
| 102 | MP0001727_abnormal_embryo_implantation | 0.78311043 |
| 103 | MP0001293_anophthalmia | 0.77042123 |
| 104 | MP0005451_abnormal_body_composition | 0.76739631 |
| 105 | MP0001919_abnormal_reproductive_system | 0.76138794 |
| 106 | MP0001873_stomach_inflammation | 0.75322109 |
| 107 | MP0003448_altered_tumor_morphology | 0.74952847 |
| 108 | MP0002090_abnormal_vision | 0.74849448 |
| 109 | MP0005360_urolithiasis | 0.74416098 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.73757138 |
| 111 | MP0008995_early_reproductive_senescence | 0.71957076 |
| 112 | MP0004233_abnormal_muscle_weight | 0.71573993 |
| 113 | MP0002084_abnormal_developmental_patter | 0.71107514 |
| 114 | MP0006082_CNS_inflammation | 0.69902531 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.69402623 |
| 116 | MP0002653_abnormal_ependyma_morphology | 0.69243983 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.68112592 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.67201780 |
| 119 | MP0005408_hypopigmentation | 0.66274818 |
| 120 | MP0003315_abnormal_perineum_morphology | 0.66102303 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.66034023 |
| 122 | MP0000358_abnormal_cell_content/ | 0.65012688 |
| 123 | MP0008469_abnormal_protein_level | 0.64383823 |
| 124 | MP0009672_abnormal_birth_weight | 0.63848671 |
| 125 | MP0009840_abnormal_foam_cell | 0.63347687 |
| 126 | MP0005384_cellular_phenotype | 0.63277879 |
| 127 | MP0005395_other_phenotype | 0.63203807 |
| 128 | MP0005621_abnormal_cell_physiology | 0.63106434 |
| 129 | MP0004197_abnormal_fetal_growth/weight/ | 0.62861360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.25874813 |
| 2 | Chromsome breakage (HP:0040012) | 3.92206622 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.91858079 |
| 4 | Breast hypoplasia (HP:0003187) | 3.90058366 |
| 5 | Abnormal protein glycosylation (HP:0012346) | 3.68118782 |
| 6 | Abnormal glycosylation (HP:0012345) | 3.68118782 |
| 7 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.68118782 |
| 8 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.68118782 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 3.40798075 |
| 10 | Multiple enchondromatosis (HP:0005701) | 3.37785746 |
| 11 | Carpal bone hypoplasia (HP:0001498) | 3.34217656 |
| 12 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.32182516 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.31267278 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.30131133 |
| 15 | Abnormality of the preputium (HP:0100587) | 3.25647724 |
| 16 | Reticulocytopenia (HP:0001896) | 3.17788383 |
| 17 | Meckel diverticulum (HP:0002245) | 3.16006706 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 3.15328959 |
| 19 | Abnormality of chromosome stability (HP:0003220) | 3.14758317 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.14242226 |
| 21 | Aplastic anemia (HP:0001915) | 3.14110071 |
| 22 | Degeneration of anterior horn cells (HP:0002398) | 3.11828760 |
| 23 | Abnormality of the anterior horn cell (HP:0006802) | 3.11828760 |
| 24 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.07651594 |
| 25 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.07651594 |
| 26 | Patellar aplasia (HP:0006443) | 3.06051536 |
| 27 | Increased CSF lactate (HP:0002490) | 3.05318783 |
| 28 | Oral leukoplakia (HP:0002745) | 3.02691168 |
| 29 | Abnormality of the ileum (HP:0001549) | 2.95925913 |
| 30 | Acute encephalopathy (HP:0006846) | 2.95903728 |
| 31 | Impulsivity (HP:0100710) | 2.91195842 |
| 32 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.89609899 |
| 33 | Mitochondrial inheritance (HP:0001427) | 2.88758449 |
| 34 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.86393186 |
| 35 | Increased serum pyruvate (HP:0003542) | 2.84206057 |
| 36 | Abnormality of glycolysis (HP:0004366) | 2.83648868 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.82247632 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.78235363 |
| 39 | Myelodysplasia (HP:0002863) | 2.75830802 |
| 40 | Abnormal spermatogenesis (HP:0008669) | 2.74129346 |
| 41 | Rough bone trabeculation (HP:0100670) | 2.73104787 |
| 42 | Bone marrow hypocellularity (HP:0005528) | 2.64909019 |
| 43 | Cholecystitis (HP:0001082) | 2.64409616 |
| 44 | Abnormal gallbladder physiology (HP:0012438) | 2.64409616 |
| 45 | Cerebral hypomyelination (HP:0006808) | 2.56523383 |
| 46 | Stenosis of the external auditory canal (HP:0000402) | 2.54336509 |
| 47 | Small intestinal stenosis (HP:0012848) | 2.54041497 |
| 48 | Duodenal stenosis (HP:0100867) | 2.54041497 |
| 49 | Abnormality of methionine metabolism (HP:0010901) | 2.52426272 |
| 50 | IgM deficiency (HP:0002850) | 2.49055268 |
| 51 | Type 2 muscle fiber atrophy (HP:0003554) | 2.47665665 |
| 52 | Macrocytic anemia (HP:0001972) | 2.46815278 |
| 53 | Increased intramyocellular lipid droplets (HP:0012240) | 2.43725373 |
| 54 | Hepatic necrosis (HP:0002605) | 2.43519170 |
| 55 | IgG deficiency (HP:0004315) | 2.42781817 |
| 56 | Lactic acidosis (HP:0003128) | 2.40924010 |
| 57 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.40485814 |
| 58 | Testicular atrophy (HP:0000029) | 2.40168991 |
| 59 | Absent thumb (HP:0009777) | 2.37091529 |
| 60 | Respiratory difficulties (HP:0002880) | 2.35369604 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.33573454 |
| 62 | Exertional dyspnea (HP:0002875) | 2.32829927 |
| 63 | Clubbing of toes (HP:0100760) | 2.32414774 |
| 64 | Cerebral edema (HP:0002181) | 2.31652747 |
| 65 | Exercise intolerance (HP:0003546) | 2.30236187 |
| 66 | Progressive macrocephaly (HP:0004481) | 2.29437450 |
| 67 | Muscle fiber atrophy (HP:0100295) | 2.28820702 |
| 68 | Type I transferrin isoform profile (HP:0003642) | 2.28621380 |
| 69 | Postnatal microcephaly (HP:0005484) | 2.28612898 |
| 70 | Pallor (HP:0000980) | 2.25014357 |
| 71 | Hypoplastic pelvis (HP:0008839) | 2.22742191 |
| 72 | Pancytopenia (HP:0001876) | 2.20777936 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.20521298 |
| 74 | Absent radius (HP:0003974) | 2.19699761 |
| 75 | Premature graying of hair (HP:0002216) | 2.19340893 |
| 76 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.18361692 |
| 77 | Lymphoma (HP:0002665) | 2.17622606 |
| 78 | Abnormal lung lobation (HP:0002101) | 2.13693336 |
| 79 | Agnosia (HP:0010524) | 2.12941856 |
| 80 | Sloping forehead (HP:0000340) | 2.11440423 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.10367486 |
| 82 | Triphalangeal thumb (HP:0001199) | 2.10055083 |
| 83 | Prominent metopic ridge (HP:0005487) | 2.09166849 |
| 84 | Thrombocytosis (HP:0001894) | 2.08913449 |
| 85 | Abnormal trabecular bone morphology (HP:0100671) | 2.08804707 |
| 86 | Progressive external ophthalmoplegia (HP:0000590) | 2.07395232 |
| 87 | Methylmalonic acidemia (HP:0002912) | 2.07207052 |
| 88 | Poikiloderma (HP:0001029) | 2.07001642 |
| 89 | Abnormality of the duodenum (HP:0002246) | 2.03225244 |
| 90 | Colon cancer (HP:0003003) | 2.03118858 |
| 91 | Ectopic kidney (HP:0000086) | 2.02955556 |
| 92 | Supernumerary spleens (HP:0009799) | 2.02534007 |
| 93 | Acute hepatic failure (HP:0006554) | 2.02439350 |
| 94 | Selective tooth agenesis (HP:0001592) | 2.02229330 |
| 95 | Cleft eyelid (HP:0000625) | 2.02211779 |
| 96 | Cellular immunodeficiency (HP:0005374) | 2.01399807 |
| 97 | Aplasia involving forearm bones (HP:0009822) | 2.00986049 |
| 98 | Absent forearm bone (HP:0003953) | 2.00986049 |
| 99 | Secondary amenorrhea (HP:0000869) | 1.99692720 |
| 100 | Abnormality of T cell physiology (HP:0011840) | 1.98583331 |
| 101 | Microretrognathia (HP:0000308) | 1.98167770 |
| 102 | Methylmalonic aciduria (HP:0012120) | 1.97980997 |
| 103 | 3-Methylglutaconic aciduria (HP:0003535) | 1.97637083 |
| 104 | Horseshoe kidney (HP:0000085) | 1.97475532 |
| 105 | Nonimmune hydrops fetalis (HP:0001790) | 1.97272732 |
| 106 | 11 pairs of ribs (HP:0000878) | 1.95661663 |
| 107 | Abnormality of the pons (HP:0007361) | 1.95565568 |
| 108 | Azoospermia (HP:0000027) | 1.95548598 |
| 109 | Pustule (HP:0200039) | 1.94525083 |
| 110 | Abnormality of T cells (HP:0002843) | 1.94069078 |
| 111 | Shoulder girdle muscle weakness (HP:0003547) | 1.93675297 |
| 112 | Pancreatic cysts (HP:0001737) | 1.93095999 |
| 113 | Sensory axonal neuropathy (HP:0003390) | 1.92980076 |
| 114 | Progressive muscle weakness (HP:0003323) | 1.92488610 |
| 115 | Microvesicular hepatic steatosis (HP:0001414) | 1.92333623 |
| 116 | Optic nerve coloboma (HP:0000588) | 1.92289149 |
| 117 | Symptomatic seizures (HP:0011145) | 1.91200088 |
| 118 | Abnormality of alanine metabolism (HP:0010916) | 1.91181416 |
| 119 | Hyperalaninemia (HP:0003348) | 1.91181416 |
| 120 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.91181416 |
| 121 | Ragged-red muscle fibers (HP:0003200) | 1.91133057 |
| 122 | Pancreatic fibrosis (HP:0100732) | 1.91111087 |
| 123 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.91027524 |
| 124 | Tracheoesophageal fistula (HP:0002575) | 1.90662879 |
| 125 | Sparse eyelashes (HP:0000653) | 1.90547153 |
| 126 | Petechiae (HP:0000967) | 1.90458832 |
| 127 | Granulocytopenia (HP:0001913) | 1.88306317 |
| 128 | Nausea (HP:0002018) | 1.88096421 |
| 129 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87925763 |
| 130 | Abnormality of the prostate (HP:0008775) | 1.86952586 |
| 131 | Neoplasm of the pancreas (HP:0002894) | 1.86141973 |
| 132 | CNS hypomyelination (HP:0003429) | 1.86135769 |
| 133 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85860704 |
| 134 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.85001597 |
| 135 | Duplicated collecting system (HP:0000081) | 1.84234715 |
| 136 | Premature ovarian failure (HP:0008209) | 1.84057633 |
| 137 | Entropion (HP:0000621) | 1.83495235 |
| 138 | Hypoplasia of the pons (HP:0012110) | 1.82907955 |
| 139 | Capillary hemangiomas (HP:0005306) | 1.82501759 |
| 140 | Irregular epiphyses (HP:0010582) | 1.81059330 |
| 141 | Increased IgM level (HP:0003496) | 1.80302705 |
| 142 | Abnormality of DNA repair (HP:0003254) | 1.80088409 |
| 143 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.78843972 |
| 144 | Encephalitis (HP:0002383) | 1.77818578 |
| 145 | Pulmonary fibrosis (HP:0002206) | 1.76119937 |
| 146 | Hyperglycinemia (HP:0002154) | 1.75999599 |
| 147 | Recurrent abscess formation (HP:0002722) | 1.74752408 |
| 148 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.74693146 |
| 149 | Abnormality of the renal collecting system (HP:0004742) | 1.74685240 |
| 150 | Eosinophilia (HP:0001880) | 1.72493105 |
| 151 | Combined immunodeficiency (HP:0005387) | 1.72201239 |
| 152 | Short thumb (HP:0009778) | 1.71246147 |
| 153 | Squamous cell carcinoma (HP:0002860) | 1.70295870 |
| 154 | Abnormality of T cell number (HP:0011839) | 1.70243418 |
| 155 | Increased serum lactate (HP:0002151) | 1.68774762 |
| 156 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.68774057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.65453406 |
| 2 | EIF2AK1 | 4.19690774 |
| 3 | WEE1 | 3.98271882 |
| 4 | VRK2 | 3.58372001 |
| 5 | SRPK1 | 2.73942840 |
| 6 | EIF2AK3 | 2.62297260 |
| 7 | CDC7 | 2.60621691 |
| 8 | PLK4 | 2.53505419 |
| 9 | STK16 | 2.41927702 |
| 10 | TSSK6 | 2.36046549 |
| 11 | ACVR1B | 2.30488100 |
| 12 | BRSK2 | 2.29706296 |
| 13 | VRK1 | 2.13377143 |
| 14 | NEK2 | 1.90802598 |
| 15 | TRIM28 | 1.86638563 |
| 16 | NME2 | 1.83682636 |
| 17 | TLK1 | 1.81924964 |
| 18 | PLK1 | 1.77580283 |
| 19 | TXK | 1.75721352 |
| 20 | IRAK3 | 1.68496752 |
| 21 | MKNK1 | 1.67972999 |
| 22 | ZAK | 1.67833681 |
| 23 | TTK | 1.64192265 |
| 24 | EIF2AK2 | 1.62713268 |
| 25 | PLK3 | 1.62566757 |
| 26 | MAP4K1 | 1.52540490 |
| 27 | DYRK3 | 1.52459216 |
| 28 | MKNK2 | 1.49006428 |
| 29 | IRAK4 | 1.46326355 |
| 30 | PDK2 | 1.45156490 |
| 31 | PIM2 | 1.43217276 |
| 32 | BCKDK | 1.38376261 |
| 33 | CDK7 | 1.36045793 |
| 34 | AURKB | 1.35432898 |
| 35 | BRSK1 | 1.35402737 |
| 36 | ATR | 1.34457494 |
| 37 | TESK2 | 1.31945190 |
| 38 | CHEK2 | 1.27798596 |
| 39 | CCNB1 | 1.27398958 |
| 40 | STK4 | 1.22315273 |
| 41 | STK10 | 1.17752104 |
| 42 | PIM1 | 1.17732545 |
| 43 | PBK | 1.10007839 |
| 44 | TAF1 | 1.07887816 |
| 45 | RPS6KB2 | 1.07668969 |
| 46 | ERBB4 | 1.05594197 |
| 47 | AURKA | 1.03556431 |
| 48 | PASK | 0.95241823 |
| 49 | TEC | 0.93641734 |
| 50 | MST4 | 0.93456511 |
| 51 | MAP3K14 | 0.93225985 |
| 52 | CHEK1 | 0.92102907 |
| 53 | PAK4 | 0.91813475 |
| 54 | NEK1 | 0.91248419 |
| 55 | EPHA2 | 0.90665468 |
| 56 | IKBKB | 0.90117279 |
| 57 | FLT3 | 0.88486756 |
| 58 | RPS6KA4 | 0.85081521 |
| 59 | JAK3 | 0.83464181 |
| 60 | BTK | 0.80769354 |
| 61 | TYK2 | 0.80620889 |
| 62 | CLK1 | 0.79682284 |
| 63 | CDK4 | 0.77004671 |
| 64 | ATM | 0.72860578 |
| 65 | IRAK2 | 0.72806201 |
| 66 | NLK | 0.71471212 |
| 67 | KDR | 0.71186522 |
| 68 | KIT | 0.71019207 |
| 69 | AKT3 | 0.69840779 |
| 70 | DYRK2 | 0.69743852 |
| 71 | STK38L | 0.67660293 |
| 72 | MAP3K8 | 0.67340522 |
| 73 | CSNK2A1 | 0.66351872 |
| 74 | ZAP70 | 0.66309416 |
| 75 | SIK3 | 0.64730146 |
| 76 | IKBKE | 0.64340931 |
| 77 | CHUK | 0.62126776 |
| 78 | RPS6KA5 | 0.61854556 |
| 79 | TAOK2 | 0.61775137 |
| 80 | TESK1 | 0.61654328 |
| 81 | CDK8 | 0.60626624 |
| 82 | SCYL2 | 0.59252810 |
| 83 | MAP3K5 | 0.58028335 |
| 84 | NEK6 | 0.57807086 |
| 85 | CSNK2A2 | 0.57593822 |
| 86 | BLK | 0.56987270 |
| 87 | CDK2 | 0.56504924 |
| 88 | MELK | 0.55111773 |
| 89 | SMG1 | 0.54722936 |
| 90 | ALK | 0.54634799 |
| 91 | STK3 | 0.54595534 |
| 92 | MAP3K3 | 0.52893502 |
| 93 | LYN | 0.50558862 |
| 94 | MAPKAPK3 | 0.50404643 |
| 95 | NME1 | 0.48508630 |
| 96 | YES1 | 0.47683917 |
| 97 | STK24 | 0.46824928 |
| 98 | CDK12 | 0.46724764 |
| 99 | ARAF | 0.46443381 |
| 100 | IRAK1 | 0.46325089 |
| 101 | GRK7 | 0.44286995 |
| 102 | PRKCI | 0.43991342 |
| 103 | TGFBR1 | 0.43899985 |
| 104 | CDK1 | 0.43446062 |
| 105 | BMPR2 | 0.40750056 |
| 106 | PAK1 | 0.39806556 |
| 107 | EEF2K | 0.39603572 |
| 108 | ADRBK2 | 0.39505125 |
| 109 | ABL2 | 0.39395300 |
| 110 | BRAF | 0.39042172 |
| 111 | MARK3 | 0.38578187 |
| 112 | MAP2K3 | 0.36356245 |
| 113 | LCK | 0.36226330 |
| 114 | TBK1 | 0.36147403 |
| 115 | NUAK1 | 0.33352538 |
| 116 | ERBB3 | 0.33191544 |
| 117 | MAP3K10 | 0.33143638 |
| 118 | SYK | 0.31155296 |
| 119 | CSF1R | 0.30736355 |
| 120 | MAPKAPK5 | 0.30493791 |
| 121 | CDK6 | 0.29239999 |
| 122 | BRD4 | 0.28519824 |
| 123 | MAP3K12 | 0.27804433 |
| 124 | ITK | 0.27684677 |
| 125 | CSNK1G3 | 0.26420592 |
| 126 | MAP3K11 | 0.25368145 |
| 127 | DAPK1 | 0.25189168 |
| 128 | CDK19 | 0.24082001 |
| 129 | MATK | 0.24081796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.01814434 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.74360121 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.52207771 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.30261199 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.00782479 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.89373808 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.80506733 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.77655321 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.59550184 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.52463834 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.45949390 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.41731290 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.36300568 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.32136878 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.28795733 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 2.22587324 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07044570 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.05163795 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.02597816 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.85100498 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.72528871 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.69800592 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.64169730 |
| 24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.59542822 |
| 25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.59111180 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.47128666 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36235197 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35177088 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29453737 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25585663 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.24155055 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23963798 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.23106089 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.22618953 |
| 35 | * mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.20175539 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15804165 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14000627 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10955652 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.06479981 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06169959 |
| 41 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04707586 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04335199 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03550324 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.02816499 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01255663 |
| 46 | Measles_Homo sapiens_hsa05162 | 0.97705426 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94290583 |
| 48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87257798 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85587193 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83969651 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83905758 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78107242 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77256933 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.75341747 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74430335 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74122462 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73474254 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73356686 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72203454 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71455659 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71172204 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70853157 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69586193 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68867645 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67726236 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67068072 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66401230 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66096629 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65668451 |
| 70 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62111890 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61610522 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60355086 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59421577 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58218827 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.54101092 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.52902480 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52518464 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48657405 |
| 79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48354512 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48085006 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45626436 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44717560 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43033075 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42674151 |
| 85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41236676 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.41232810 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40512785 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40453606 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40248861 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39111926 |
| 91 | Peroxisome_Homo sapiens_hsa04146 | 0.37687557 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.37427152 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37384242 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36305740 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36192936 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35623338 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34797441 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34308123 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33103100 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.32414303 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31081305 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28370746 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27724463 |
| 104 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27680951 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25875693 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25732204 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.24988425 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.24810148 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.23347635 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23011998 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22336488 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.21529955 |
| 113 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.19536088 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18936446 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.18434756 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.18251166 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.17133129 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.15958263 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.15865895 |
| 120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.15774136 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.15304659 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15146415 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.14956095 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.14169887 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12699985 |
| 126 | Carbon metabolism_Homo sapiens_hsa01200 | 0.12682874 |

